Tag archive
A 2023 UK study showed 20% of patients on semaglutide lost weight while cutting back on alcohol. Discover the seven ways this drug could treat both conditions a
Tirzepatide triggers more ketoacidosis cases than semaglutide, according to FDA reports. I break down the numbers, why it matters, and how to protect patients.
Explore real‑world oral semaglutide adherence, weight‑loss outcomes, and cardiovascular benefits versus injectables.
92% of GLP‑1 starters lose weight faster, yet most patients are lost on how to begin. I break down the insurance maze, dosing tricks, and real‑world tips so you
A 12% drop in heart attacks from a single weekly shot flips the script on semaglutide’s safety. Discover why this drug may protect your heart as it trims pounds
Over 300 euglycemic ketoacidosis reports have surfaced among non‑diabetic patients on semaglutide. Discover why this matters for weight‑loss prescribing and how
Half of FDA ketoacidosis reports in obesity are tied to semaglutide, while tirzepatide shows a markedly lower pattern. Learn why this matters for prescribing we
Introduction to Ozempic and Bipolar Disorder Ozempic, a medication primarily used to treat...
Tirzepatide trims more weight than semaglutide, but the latter is gentler on the stomach. Find out which drug fits your weight‑loss journey and why the first 12
Could a Weight‑Loss Drug Rewrite the Rules of Athletic Competition? The return of...
If you've been getting compounded semaglutide from a telehealth platform or compounding pharmacy,...
A new study shows semaglutide can cut weight by nearly 30% compared with placebo, yet an 8% rebound risk looms. Discover why the safety profile matters before y